SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
137 hedge funds and large institutions have $170M invested in Synergy Pharmaceuticals, Inc Common Stock in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
39% less call options, than puts
Call options by funds: $3.39M | Put options by funds: $5.54M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
137
Holding in Top 10
–
Calls
$3.39M
Puts
$5.54M
Top Buyers
| 1 | +$881K | |
| 2 | +$808K | |
| 3 | +$768K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$725K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$567K |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$3.23M | |
| 3 | -$2.73M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.98M |
| 5 |
Morgan Stanley
New York
|
-$1.67M |